from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0858c/dapC

LFCtreatmentdescriptionclass of inhibitor

-0.746

Amikacinug/mL Amikacintranslation

-0.774

Cap5-10ug/mL Capreomycintranslation

-1.917

Rox10-50 ug/mL Roxithromycintranslation

-0.045

SM2-5 ug/mL Streptomycintranslation

0.552

Tet5-10 ug/mL Tetracyclinetranslation

0.443

Rif0.2-5ug/mL Rifampicintranscription

0.504

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.269

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.319

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

1.165

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.144

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.058

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.334

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.062

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.975

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.321

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.225

Nigericin50 uM Nigericinrespiration

-0.523

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.544

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.101

menadione6-10 ug/mL Menadionerespiration

-0.364

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.933

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.056

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.599

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.923

NRP_1Non-replicating persistence stage 1dosRassociated

1.211

Amp0.2mg/mL AmpicillincellWall

-0.172

Cephalexin20-100 ug/mL CephalexincellWall

0.014

Cerulenin0.32-5 ug/mL CerulenincellWall

0.077

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.181

EMB10-20 ug/mL EthambutolcellWall

0.568

Eta12-40 ug/mL EthionamidecellWall

-1.539

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.117

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.708

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.698

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.295

BZA0.12 mg/mL BenzamidearomaticAmides

0.758

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.105

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.032

H2O24 mM hydrogen peroxideDNAdamaging

-0.140

Levo10 ug/mL LevofloxacinDNAdamaging

0.289

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.962

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.349

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.416

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.332

Antimycin12.5-50 ug/mL Antimycin A?

-0.420

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.292

PA_110-50 ug/mL Antitubercular compound PA-1?

0.035

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.605

PA8240.2-2 ug/mL PA-824?

-0.764

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.124

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.240

Verapamil50 uM Verapamil?

-0.685

mercaptoethanol2 mM 2-Mercaptoethanol?

0.469

methoxatin10-20 ug/mL Methoxatin?